Full Breakdown
Resignations Within HHS Over Flavored Vaping Policy
5/14/2026, 2:09:39 AM
Resignations Over Flavored Vaping Policy
Rich Danker, the assistant secretary for public affairs at the Department of Health and Human Services (HHS) and chief spokesman for Health Secretary Robert F. Kennedy Jr., resigned on Wednesday, citing protest against the administration’s effort to permit major tobacco firms to sell flavored e-cigarettes that appeal to children. His departure follows the resignation of FDA commissioner Dr. Marty Makary on Tuesday for the same reason. Earlier, Thomas Corry, Kennedy’s first top spokesman, also quit after a brief tenure.
Background: FDA Policy Shift and Internal Opposition
The Food and Drug Administration recently posted a policy outlining steps to remove illicit e-cigarettes and to allow sales of products that have cleared specific approval hurdles. Senior HHS officials have reportedly sought FDA marketing approval for flavored e-cigarette products targeting youth. Dr. Makary attempted to block such marketing but was overruled, and President Donald Trump is reported to have personally advanced the policy.
Key Figures
- Rich Danker – Assistant secretary for public affairs, HHS; resigned in protest.
- Robert F. Kennedy Jr. – Secretary of Health, overseeing HHS.
- Dr. Marty Makary – Former FDA commissioner, resigned over flavored-vape policy.
- President Donald Trump – Involved in advancing the flavored-vape initiative.
- Thomas Corry – Former top spokesman for Kennedy, resigned after two weeks.
Timeline of Recent Departures
- May 13 2026 – Dr. Marty Makary resigns as FDA commissioner.
- May 14 2026 – Rich Danker resigns as HHS assistant secretary for public affairs.
- Earlier 2026 – Thomas Corry resigns after a two-week tenure.
- Current – Positions of surgeon general and CDC director remain vacant.
Potential Public Health Impact
Officials warn that authorizing flavored e-cigarettes could increase youth vaping, exposing children to nicotine addiction, lung damage, and a heightened risk of cancer.
Why It Matters
The resignations leave HHS with multiple senior vacancies, potentially hampering policy implementation and public-health coordination. The controversy also highlights broader political tensions over youth-targeted tobacco products.
Official Statements & Responses
In a letter to President Trump, Danker praised the president’s past achievements while warning that routine approval of flavored products would undermine a March FDA policy supported by the White House. The letter also cited unnamed senior HHS officials who have pursued FDA approval for youth-appealing flavors. No formal response from the White House has been reported. Kennedy is scheduled to speak at a conference on diet and cancer, underscoring his continued public-health agenda.
Criticism & Opposition
Danker’s resignation, echoed by Makary’s earlier departure, signals internal dissent against the flavored-vape push. Corry’s exit over the handling of a measles outbreak further illustrates friction within the department’s communications team.
Conflicting Reports & Gaps
Sources provide no quantitative projections of increased youth vaping, no specific tobacco companies identified, and no direct statement from President Trump regarding the policy’s rationale.
Verbatim Quotes
- “twice restored our prosperity and national security against all odds.” — Rich Danker, in letter to President Trump
- “Senior H.H.S. officials in the immediate office of the secretary have in recent months sought U.S. Food and Drug Administration marketing approval of e-cigarette flavors that would appeal to children and expose them to nicotine addiction, lung damage and higher risk of cancer,” — Rich Danker
- “with the support of the White House.” — Rich Danker
What’s Next
HHS must fill the vacant senior posts while the administration faces scrutiny over its flavored-vape strategy. Ongoing investigations and potential legislative actions may shape future regulatory approaches to youth vaping.
